|
A study with Gemzar and LY293111 in patients with pancreatic cancer. Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about A study with Gemzar and LY293111 in patients with pancreatic cancer. conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A study with Gemzar and LY293111 in patients with pancreatic cancer. Clinical research trials and A study with Gemzar and LY293111 in patients with pancreatic cancer. medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as A study with Gemzar and LY293111 in patients with pancreatic cancer.. A study with Gemzar and LY293111 in patients with pancreatic cancer. Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a A study with Gemzar and LY293111 in patients with pancreatic cancer. clinical trial. Participants frequently get the best healthcare available for their A study with Gemzar and LY293111 in patients with pancreatic cancer. condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A study with Gemzar and LY293111 in patients with pancreatic cancer.  A study with Gemzar and LY293111 in patients with pancreatic cancer.
A study with Gemzar and LY293111 in patients with pancreatic cancer.
For Condition: Pancreatic Cancer
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine in patients with pancreatic cancer.
Details:
Eligibility:
Study Type: Interventional,�Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Adenocarcinoma of the pancreas - Tumor that can be measured by x-ray or scan - Adequate organ function Exclusion Criteria: - Inability to swallow capsules - Documented brain metastases - Previous treatment for this cancer
Total Enrollment:
Location and Contact Information:
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Lakeland, Florida,
United States
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Houston, Texas,
United States
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Helsinki, ,
Finland
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Birmingham, Alabama,
United States
Recruiting
Additional Information:
Study ID Numbers: 4840;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00055250
Other Pancreatic Cancer Studies:
1. LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
2. Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
3. Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
4. A Randomized, Phase II, Study of TNFerade™ Biologic with 5-FU and Radiation Therapy for first-line treatment of Unresectable, Locally Advanced Pancreatic Cancer.
5. A Study to Test the Effectiveness of Virulizin® Given in Combination with Standard Chemotherapy for Pancreatic Cancer
Related Studies:
Other Pancreatic Cancer Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials
A study with Gemzar and LY293111 in patients with pancreatic cancer.
|
|
|
|
|
|
|
|
